| |
|
|
|
Aspect Biosystems Appoints Three New Board Members
|
|
Vancouver, BC, October 5, 2022--Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat disease, announced the appointment of three new members to its Board of Directors: Dr. Nancy Krieger, Dr. Don Haut, and Dr. Devyn Smith.
|
|
|
|
|
|
|
|
Aspect Biosystems Appoints Five New Scientific Advisors
|
|
Vancouver, BC, June 13, 2022--Aspect Biosystems, a biotechnology company pioneering the development of bioengineered tissue therapeutics to transform how we treat disease, announced the appointment of five new advisors to the Company's Scientific Advisory Board (SAB). Appointments include Dr. James Shapiro, Dr. Anil Dhawan, Dr. Jane Lebkowski, Dr. Shinichiro Ogawa, and Dr. Omid Veiseh.
|
|
|
|
|
|
|
|
Aspect Biosystems Enters Collaboration With McMaster University
|
|
Vancouver, BC, September 3, 2019--Aspect Biosystems, a Canadian biotech company pioneering microfluidic 3D bioprinting of human tissues, is pleased to announce a collaboration with Dr. Jeremy Hirota - Canada Research Chair in Respiratory Mucosal Immunology - at the Firestone Institute for Respiratory Health located at McMaster University.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aspect Biosystems Announces Liver Tissue Collaboration With JSR
|
|
Vancouver, BC, September 25, 2018--Aspect Biosystems, a privately held biotechnology company focused on commercializing cutting-edge bioprinting technologies, announced a new collaboration to develop human liver tissue with JSR Corporation, a leading materials supplier in a variety of technology driven markets.
|
|
|
|
|
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
Employers
Post Job Listings
Advertise
